MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202617089730 A) filed by Eli Lilly And Company on July 23, 2026, for Novel Compounds As Glp-1r Agonists And Uses Thereof.
Inventors include Ding, Xiao; Yu, Huaxing; Ren, Feng; Wan, Jianfei; Zhang, Haoyu; and Chen, Yi-Jang.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: Described herein are GLP-1R agonists and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of a GLP-1 associated disease or disorder, including Type 2 diabetes or obesity.
Disclaimer: Curated by HT Syndication.
